Renalytix - Total Assets 2020-2024 | RNLXY

Renalytix - total assets from 2020 to 2024. Total assets can be defined as the sum of all assets on a company's balance sheet.
Renalytix - Annual Total Assets
(Millions of US $)
2024 $8
2023 $31
2022 $50
2021 $79
2020 $21
2019 $0
2019 $10
Renalytix - Quarterly Total Assets
(Millions of US $)
2024-09-30 $5
2024-06-30 $8
2024-03-31 $9
2023-12-31 $11
2023-09-30 $20
2023-06-30 $31
2023-03-31 $40
2022-12-31 $31
2022-09-30 $39
2022-06-30 $50
2022-03-31 $44
2021-12-31 $54
2021-09-30 $67
2021-06-30 $79
2021-03-31 $85
2020-12-31 $91
2020-09-30 $91
2020-06-30 $21
2020-03-31 $0
2019-12-31 $0
2019-09-30 $0
2019-06-30 $10
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.030B $0.002B
Renalytix plc is an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease to drive improved patient outcomes and advance value-based care. Renalytix plc, formerly known as RENALYTIX AI, is based in NEW YORK.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $47.457B 60.38
Hims & Hers Health (HIMS) United States $12.904B 134.07
Doximity (DOCS) United States $11.414B 52.84
Tempus AI (TEM) United States $11.164B 0.00
IRhythm Technologies (IRTC) United States $4.284B 0.00
Inspire Medical Systems (INSP) United States $3.801B 59.38
Hinge Health (HNGE) United States $3.571B 0.00
Privia Health (PRVA) United States $2.402B 164.21
10x Genomics (TXG) United States $1.737B 0.00
Schrodinger (SDGR) United States $1.631B 0.00
Phreesia (PHR) United States $1.585B 0.00
Azenta (AZTA) United States $1.576B 73.25
Enovis (ENOV) United States $1.573B 8.77
Clover Health Investments (CLOV) United States $1.545B 0.00
Omnicell (OMCL) United States $1.324B 23.36
Evolent Health (EVH) United States $1.166B 99.30
Claritev (CTEV) United States $0.652B 0.00
Fulgent Genetics (FLGT) United States $0.559B 0.00
Standard BioTools (LAB) United States $0.532B 0.00
Veradigm (MDRX) United States $0.503B 0.00
Butterfly Network (BFLY) United States $0.487B 0.00
Talkspace (TALK) United States $0.421B 125.75
TruBridge (TBRG) United States $0.353B 783.33
Outset Medical (OM) United States $0.328B 0.00
Health Catalyst (HCAT) United States $0.270B 0.00
Nyxoah SA (NYXH) Belgium $0.258B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.240B 0.00
CapsoVision (CV) United States $0.185B 0.00
Zepp Health (ZEPP) Netherlands $0.161B 0.00
KORU Medical Systems (KRMD) United States $0.160B 0.00
American Well (AMWL) United States $0.140B 0.00
Pulmonx (LUNG) United States $0.134B 0.00
EUDA Health Holdings (EUDA) Singapore $0.118B 0.00
MDxHealth SA (MDXH) Belgium $0.118B 0.00
CareCloud (CCLD) United States $0.104B 3.95
ImmunoPrecise Antibodies (IPA) Canada $0.099B 0.00
Insight Molecular Diagnostics (IMDX) United States $0.083B 0.00
111 (YI) China $0.063B 0.00
P3 Health Partners (PIII) United States $0.052B 0.00
HeartBeam (BEAT) United States $0.043B 0.00
Zhongchao (ZCMD) China $0.026B 0.00
Streamline Health Solutions (STRM) United States $0.023B 0.00
Precipio (PRPO) United States $0.022B 0.00
Bullfrog AI Holdings (BFRG) United States $0.014B 0.00
Strata Skin Sciences (SSKN) United States $0.008B 0.00
Predictive Oncology (POAI) United States $0.008B 0.00
MSP Recovery (MSPR) United States $0.008B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.006B 0.00
Movano (MOVE) United States $0.005B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Evaxion - (EVAX) Denmark $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.004B 0.00
PROFUSA (PFSA) United States $0.004B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00
Healthcare Triangle (HCTI) United States $0.000B 0.00